RAPID: IFRT versus No Further Treatment in Patients with Early-Stage Hodgkin Lymphoma and Negative PET Scan After 3 ABVD Cycles


RAPID: IFRT versus No Further Treatment in Patients with Early-Stage Hodgkin Lymphoma and Negative PET Scan After 3 ABVD Cycles
Slides from a presentation at ASH 2012 and transcribed comments from a recent interview with Bruce D Cheson, MD (1/14/13)

Radford J et al. Involved field radiotherapy versus no further treatment in patients with clinical Stages IA and IIA Hodgkin lymphoma and a ‘negative’ PET scan after 3 cycles ABVD. Results of the UK NCRI RAPID trial. Proc ASH 2012;Abstract 547.

Dr Cheson is Professor of Medicine, Deputy Chief of the Division of Hematology-Oncology and Head of Hematology at the Georgetown University Hospital Lombardi Comprehensive Cancer Center in Washington, DC.